New User? Sign Up | Sign In

Insider Trading - KalVista Pharmaceuticals Inc. (KALV)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
KALV Insider Trading Transactions for KalVista Pharmaceuticals Inc.
Goto page 0, 1, 2, 3, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-02-05
Sale
2020-02-07
5:18 pm
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
100 $17.1 $1,710 82,869
(Direct)
View
2020-02-05
Sale
2020-02-07
5:17 pm
KalVista Pharmaceuticals Inc. KALV Feener Edward P.
Chief Scientific Officer
100 $17.11 $1,711 96,634
(Direct)
View
2020-02-05
Sale
2020-02-07
5:14 pm
KalVista Pharmaceuticals Inc. KALV Crockett Thomas Andrew
CEO
200 $17.05 $3,410 238,220
(Direct)
View
2019-12-20
Sale
2019-12-26
5:32 pm
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
2,646 $17.02 $45,025 82,969
(Direct)
View
2019-12-20
Sale
2019-12-26
5:30 pm
KalVista Pharmaceuticals Inc. KALV Crockett Thomas Andrew
CEO
2,300 $17.02 $39,150 238,420
(Direct)
View
2019-12-12
Sale
2019-12-16
7:34 pm
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
4,709 $17.05 $80,269 82,969
(Direct)
View
2019-12-12
Sale
2019-12-16
7:32 pm
KalVista Pharmaceuticals Inc. KALV Crockett Thomas Andrew
CEO
7,700 $17.06 $131,352 240,720
(Direct)
View
2019-09-26
Purchase
2019-09-30
5:23 pm
KalVista Pharmaceuticals Inc. KALV SOLAND DANIEL B
Director
10,000 $11.87 $118,750 10,000
(Direct)
View
2019-07-26
Purchase
2019-07-30
7:37 pm
KalVista Pharmaceuticals Inc. KALV Cha Albert
Director
56,367 $16.99 $957,737 124,566
(Indirect)
View
2019-07-22
Sale
2019-07-24
5:53 pm
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
7,355 $18.35 $134,930 82,969
(Direct)
View
2019-07-22
Sale
2019-07-24
5:52 pm
KalVista Pharmaceuticals Inc. KALV Feener Edward P.
Chief Scientific Officer
3,300 $18.62 $61,443 96,734
(Direct)
View
2019-07-17
Purchase
2019-07-19
6:38 pm
KalVista Pharmaceuticals Inc. KALV Cha Albert
Director
61,280 $17.79 $1,090,296 975,821
(Indirect)
View
2019-07-15
Sale
2019-07-17
6:52 pm
KalVista Pharmaceuticals Inc. KALV Crockett Thomas Andrew
CEO
10,000 $17.04 $170,407 248,510
(Direct)
View
2019-04-22
Sale
2019-04-23
5:33 pm
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
7,355 $26.04 $191,530 82,969
(Direct)
View
2019-04-15
Sale
2019-04-23
5:30 pm
KalVista Pharmaceuticals Inc. KALV Crockett Thomas Andrew
CEO
10,000 $24.8 $247,958 258,510
(Direct)
View
2019-04-18
Sale
2019-04-22
5:58 pm
KalVista Pharmaceuticals Inc. KALV Palleiko Benjamin L
CFO
3,073 $25.7 $78,976 32,500
(Direct)
View
2019-04-17
Sale
2019-04-18
6:30 pm
KalVista Pharmaceuticals Inc. KALV Feener Edward P.
Chief Scientific Officer
4,000 $24.92 $99,666 100,034
(Direct)
View
2019-04-08
Sale
2019-04-10
7:21 pm
KalVista Pharmaceuticals Inc. KALV SVLSF IV LLC
SV Life Sciences Fund IV (GP) L.P.
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P.
SV LIFE SCIENCES FUND IV L.P.
10% Owner
50,000 $29.2 $1,460,145 47,471
(Direct)
View
2019-04-05
Sale
2019-04-09
5:33 pm
KalVista Pharmaceuticals Inc. KALV Maetzel Andreas
VP
5,000 $30 $150,011 0
(Direct)
View
2019-03-29
Sale
2019-04-02
6:57 pm
KalVista Pharmaceuticals Inc. KALV SVLSF IV LLC
SV Life Sciences Fund IV (GP) L.P.
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P.
SV LIFE SCIENCES FUND IV L.P.
10% Owner
97,074 $28.03 $2,720,897 48,851
(Direct)
View
2019-03-26
Sale
2019-03-28
5:29 pm
KalVista Pharmaceuticals Inc. KALV SVLSF IV LLC
SV Life Sciences Fund IV (GP) L.P.
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P.
SV LIFE SCIENCES FUND IV L.P.
10% Owner
124,675 $28.84 $3,596,032 51,531
(Direct)
View
2019-03-18
Sale
2019-03-20
4:13 pm
KalVista Pharmaceuticals Inc. KALV SVLSF IV LLC
SV Life Sciences Fund IV (GP) L.P.
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P.
SV LIFE SCIENCES FUND IV L.P.
10% Owner
262,470 $26.7 $7,007,949 54,973
(Direct)
View
2019-03-18
Sale
2019-03-20
4:08 pm
KalVista Pharmaceuticals Inc. KALV Venrock Healthcare Capital Partners II L.P.
VHCP Co-Investment Holdings II LLC
VHCP Management II LLC
Venrock Healthcare Capital Partners III L.P.
VHCP Co-Investment Holdings III LLC
VHCP Management III LLC
Koh Bong Y
Shah Nimish P
10% Owner
500,000 $28.75 $14,375,000 1,544,112
(Indirect)
View
2019-03-14
Sale
2019-03-15
8:03 pm
KalVista Pharmaceuticals Inc. KALV Crockett Thomas Andrew
CEO
3,000 $30.16 $90,484 268,510
(Direct)
View
2019-03-04
Sale
2019-03-06
09:05 am
KalVista Pharmaceuticals Inc. KALV SVLSF IV LLC
SV Life Sciences Fund IV (GP) L.P.
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P.
SV LIFE SCIENCES FUND IV L.P.
10% Owner
75,710 $22.96 $1,738,476 62,219
(Direct)
View
2019-02-19
Sale
2019-02-21
2:35 pm
KalVista Pharmaceuticals Inc. KALV SVLSF IV LLC
SV Life Sciences Fund IV (GP) L.P.
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P.
SV LIFE SCIENCES FUND IV L.P.
10% Owner
214,198 $20.55 $4,401,353 64,309
(Direct)
View
2019-01-25
Sale
2019-01-29
6:53 pm
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
5,453 $17.06 $93,015 82,969
(Direct)
View
2019-01-22
Sale
2019-01-24
7:48 pm
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
1,902 $17.01 $32,344 82,969
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-12-20
Exercise
2019-12-26
5:32 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
2,646 $0.0043 82,969
(Direct)
View
2019-12-20
Exercise
2019-12-26
5:32 pm
N/A
2026-03-30
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
2,646 $0.0043 82,969
(Direct)
View
2019-12-12
Exercise
2019-12-16
7:34 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
199 $0.0043 82,969
(Direct)
View
2019-12-12
Exercise
2019-12-16
7:34 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
1,500 $0.0043 82,969
(Direct)
View
2019-12-12
Exercise
2019-12-16
7:34 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
3,010 $0.0043 82,969
(Direct)
View
2019-12-12
Exercise
2019-12-16
7:34 pm
N/A
2026-03-30
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
199 $0.0043 82,969
(Direct)
View
2019-12-12
Exercise
2019-12-16
7:34 pm
N/A
2026-03-30
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
1,500 $0.0043 82,969
(Direct)
View
2019-12-12
Exercise
2019-12-16
7:34 pm
N/A
2026-03-30
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
3,010 $0.0043 82,969
(Direct)
View
2019-10-02
Option Award
2019-10-03
5:26 pm
N/A
2029-10-01
KalVista Pharmaceuticals Inc. KALV Cha Albert
Director
7,000 $11.21 7,000
(Direct)
View
2019-10-02
Option Award
2019-10-03
5:25 pm
N/A
2029-10-01
KalVista Pharmaceuticals Inc. KALV ORONSKY ARNOLD L
Director
7,000 $11.21 7,000
(Direct)
View
2019-10-02
Option Award
2019-10-03
5:24 pm
N/A
2029-10-01
KalVista Pharmaceuticals Inc. KALV Unkart Edward W
Director
7,000 $11.21 7,000
(Direct)
View
2019-07-22
Exercise
2019-07-24
5:53 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
7,355 $0.0043 82,969
(Direct)
View
2019-07-22
Exercise
2019-07-24
5:53 pm
N/A
2026-03-30
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
7,355 $0.0043 82,969
(Direct)
View
2019-06-26
Option Award
2019-06-28
5:36 pm
N/A
2019-06-25
KalVista Pharmaceuticals Inc. KALV Edwards Martin
Director
14,000 $20.62 14,000
(Direct)
View
2019-05-15
Option Award
2019-05-17
5:44 pm
N/A
2029-05-14
KalVista Pharmaceuticals Inc. KALV Palleiko Benjamin L
CFO
33,750 $24.23 33,750
(Direct)
View
2019-05-15
Option Award
2019-05-17
5:34 pm
N/A
2029-05-14
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
27,900 $24.23 27,900
(Direct)
View
2019-05-15
Option Award
2019-05-17
5:29 pm
N/A
2029-05-14
KalVista Pharmaceuticals Inc. KALV Maetzel Andreas
VP
9,000 $24.23 9,000
(Direct)
View
2019-05-15
Option Award
2019-05-17
5:22 pm
N/A
2029-05-14
KalVista Pharmaceuticals Inc. KALV Feener Edward P.
Chief Scientific Officer
20,250 $24.23 20,250
(Direct)
View
2019-05-15
Option Award
2019-05-17
5:17 pm
N/A
2029-05-14
KalVista Pharmaceuticals Inc. KALV Crockett Thomas Andrew
CEO
67,500 $24.23 67,500
(Direct)
View
2019-04-22
Exercise
2019-04-23
5:33 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
7,355 $0.0043 82,969
(Direct)
View
2019-04-22
Exercise
2019-04-23
5:33 pm
N/A
2026-03-30
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
7,355 $0.0043 82,969
(Direct)
View
2019-04-22
Option Award
2019-04-23
5:29 pm
N/A
2029-04-21
KalVista Pharmaceuticals Inc. KALV SOLAND DANIEL B
Director
14,000 $26.4 14,000
(Direct)
View
2019-04-18
Exercise
2019-04-22
5:58 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Palleiko Benjamin L
CFO
1,073 $6.74 32,500
(Direct)
View
2019-04-18
Exercise
2019-04-22
5:58 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Palleiko Benjamin L
CFO
2,000 $8.39 32,500
(Direct)
View
2019-04-18
Exercise
2019-04-22
5:58 pm
N/A
2026-12-28
KalVista Pharmaceuticals Inc. KALV Palleiko Benjamin L
CFO
1,073 $6.74 32,500
(Direct)
View
2019-04-18
Exercise
2019-04-22
5:58 pm
N/A
2026-11-21
KalVista Pharmaceuticals Inc. KALV Palleiko Benjamin L
CFO
2,000 $8.39 32,500
(Direct)
View
2019-04-05
Exercise
2019-04-09
5:33 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Maetzel Andreas
VP
5,000 $7.91 0
(Direct)
View
2019-04-05
Exercise
2019-04-09
5:33 pm
N/A
2027-03-07
KalVista Pharmaceuticals Inc. KALV Maetzel Andreas
VP
5,000 $7.91 0
(Direct)
View
2019-02-01
Option Award
2019-02-05
5:41 pm
N/A
2029-01-31
KalVista Pharmaceuticals Inc. KALV Pereira Brian JG
Director
14,000 $17.95 14,000
(Direct)
View
2019-01-25
Exercise
2019-01-29
6:53 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
5,453 $0.0043 82,969
(Direct)
View
2019-01-25
Exercise
2019-01-29
6:53 pm
N/A
2026-03-30
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
5,453 $0.0043 82,969
(Direct)
View
2019-01-22
Exercise
2019-01-24
7:48 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
1,302 $0.0043 82,969
(Direct)
View
2019-01-22
Exercise
2019-01-24
7:48 pm
N/A
N/A
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
600 $0.0043 82,969
(Direct)
View
2019-01-22
Exercise
2019-01-24
7:48 pm
N/A
2026-03-30
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
1,302 $0.0043 82,969
(Direct)
View
2019-01-22
Exercise
2019-01-24
7:48 pm
N/A
2026-03-30
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
600 $0.0043 82,969
(Direct)
View
2016-11-21
Option Award
2019-01-24
7:44 pm
N/A
2026-03-30
KalVista Pharmaceuticals Inc. KALV Yea Christopher
Chief Development Officer
116,810 $0.0043 116,810
(Direct)
View
Goto page 0, 1, 2, 3, Next